CNTX icon

Context Therapeutics
CNTX

Overview Fund Activity

19 hedge funds and large institutions have $9.44M invested in Context Therapeutics in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+19
Holders Change %
–
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
$3.27M
2
ACM
AIGH Capital Management
Maryland
$2.03M
3
ACM
Altium Capital Management
New York
$1.31M
4
Vanguard Group
Vanguard Group
Pennsylvania
$571K
5
WVP
Worth Venture Partners
New Jersey
$465K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$3.27M +$3.27M +1,230,830 New
ACM
2
AIGH Capital Management
Maryland
$2.03M +$2.03M +762,721 New
ACM
3
Altium Capital Management
New York
$1.31M +$1.31M +493,531 New
EAM
4
Empery Asset Management
New York
$954K +$954K +358,617 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$571K +$571K +214,679 New
WVP
6
Worth Venture Partners
New Jersey
$465K +$465K +174,967 New
V
7
Veritable
Delaware
$293K +$293K +110,249 New
Renaissance Technologies
8
Renaissance Technologies
New York
$172K +$172K +64,618 New
VF
9
Virtu Financial
New York
$142K +$142K +53,521 New
S
10
swisspartners
Liechtenstein
$114K +$114K +42,235 New
QC
11
QCM Cayman
Texas
$37K +$37K +14,041 New
BlackRock
12
BlackRock
New York
$31K +$31K +11,547 New
HF
13
HRT Financial
New York
$27K +$27K +10,160 New
Morgan Stanley
14
Morgan Stanley
New York
$13K +$13K +5,000 New
TRCT
15
Tower Research Capital (TRC)
New York
$6K +$6K +2,054 New
AWA
16
Amplius Wealth Advisors
Pennsylvania
$1K +$1K +600 New